About
▼
Careers
Internship
MedBlog
Contact us
English (US)
▼
LOGIN
REGISTER
☰
Explore
Healthy Living
News
Health A-Z
Calculators
Articles
Drugs
Directories
Education
More
Latest Press Releases
Submit Press Releases
‹
›
Advertisement
Medindia
»
Health Press Releases A-Z
New Synergy Collection By StemCutis Rejuvenates Skin And Repairs Signs Of Aging
Wednesday, March 8, 2017
Genetics & Stem Cells News
Advertisement
Latest Press Release on Genetics & Stem Cells News
SCG Cell Therapy Presented New Preclinical Data in an Oral Presentation at ASGCT 2024 Annual Meeting Highlighting Superior Tumor Inhibition of its Immunoswitch Armored HPV-TCR T Cell Therapy (SCG142) against a Broad Range of HPV-associated Cancers
SINGAPORE , May 12, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing novel immunotherapies for infectious diseases and their ...
Medical College of Wisconsin Cancer Center leads groundbreaking change in Medicare policy for MDS patients over 65 in need of lifesaving transplants
MILWAUKEE , May 8, 2024 /PRNewswire/ -- The Centers for Medicare & Medicaid Services recently issued a decision to expand Medicare coverage for allogeneic hematopoietic stem cell ...
BioLineRx Announces Poster Presentation on Economic Model Data for APHEXDAŽ (motixafortide) as part of CD34+ Hematopoietic Stem Cell Mobilization in Patients with Multiple Myeloma at ISPOR 2024
- Presentation Today, Monday, May 6, 2024 in Atlanta , Georgia - TEL AVIV, Israel , May 6, 2024 /PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial s...
Early Check Newborn Screening Study Taps Revvity to Provide Genome Sequencing
The North Carolina -based study will continue to test enrolled newborns for hundreds of childhood-onset rare genetic conditions RESEARCH TRIANGLE PARK, N.C. and WALTHAM, Mass. ...
GeneVentiv Therapeutics Awarded $2.5 Million SBIR Grant to Advance Gene Therapy for All Hemophilias, with or without Inhibitors
Damon R. Race , President & CEO RALEIGH, N.C. , April 16, 2024 /PRNewswire/ -- GeneVentiv Therapeutics, developer of GENV-HEM (AAV8.FVa) for all hemophilias, announced to...
About Us
Editorial Team
Exclusive Interviews
In the News
Partners & Affiliates
Advertise With Us
Sitemap
हिन्दी
français
Español
中文
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our
Cookie Policy
,
Privacy Policy
, and our
Terms of Use
Ok, Got it.
Close
↑